BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37095423)

  • 21. DLEU2/EZH2/GFI1 Axis Regulates the Proliferation and Apoptosis of Human Bone Marrow Mesenchymal Stem Cells.
    Yao Q; He X; Wang J; Liu J; Zhang Q; Zhang J; Bo Y; Lu L
    Crit Rev Eukaryot Gene Expr; 2024; 34(3):61-71. PubMed ID: 38305289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Tumor-related LncRNA PART1 in Cancer.
    Chen J; Meng E; Lin Y; Shen Y; Hu C; Zhou G; Yuan C
    Curr Pharm Des; 2021; 27(40):4152-4159. PubMed ID: 34225608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The lncRNA-DLEU2/miR-186-5p/PDK3 axis promotes the progress of glioma cells.
    Xie Z; Li X; Chen H; Zeng A; Shi Y; Tang Y
    Am J Transl Res; 2019; 11(8):4922-4934. PubMed ID: 31497209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Circular RNA DLEU2 in Human Acute Myeloid Leukemia.
    Wu DM; Wen X; Han XR; Wang S; Wang YJ; Shen M; Fan SH; Zhang ZF; Shan Q; Li MQ; Hu B; Chen GQ; Lu J; Zheng YL
    Mol Cell Biol; 2018 Oct; 38(20):. PubMed ID: 30037980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knockdown of LncRNA DLEU2 Inhibits Cervical Cancer Progression via Targeting miR-128-3p.
    Wang B; Hang J; Li W; Yuan W
    Onco Targets Ther; 2020; 13():10173-10184. PubMed ID: 33116599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
    Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
    Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNA DLEU2 drives the malignant behaviors of thyroid cancer through mediating the miR-205-5p/TNFAIP8 axis.
    Yang J; Huang Y; Dong B; Dai Y
    Endocr Connect; 2021 Apr; 10(4):471-483. PubMed ID: 33764889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA H19: a potential biomarker and therapeutic target in human malignant tumors.
    Zhang R; Zeng Y; Deng JL
    Clin Exp Med; 2023 Sep; 23(5):1425-1440. PubMed ID: 36484927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. WDFY3-AS2: A Potential Prognostic Factor and Therapeutic Target Related to Cancer.
    Mou J; Chen J; Wu Y; He Y; Zhou G; Yuan C
    Curr Med Chem; 2023; 30(25):2814-2821. PubMed ID: 36093824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
    Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
    Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth arrest-specific 5 lncRNA as a valuable biomarker of chemoresistance in osteosarcoma.
    Polvani S; Martignano F; Scoccianti G; Pasqui A; Palomba AR; Conticello S; Galli A; Palchetti I; Caporalini C; Antonuzzo L; Campanacci DA; Pillozzi S
    Anticancer Drugs; 2022 Mar; 33(3):278-285. PubMed ID: 35045526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA.
    Shi X; Zhang W; Nian X; Lu X; Li Y; Liu F; Wang F; He B; Zhao L; Zhu Y; Ren S; Sun Y
    Int J Cancer; 2020 Jan; 146(2):475-486. PubMed ID: 31107971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MCM3AP-AS1: A LncRNA Participating in the Tumorigenesis of Cancer Through Multiple Pathways.
    Wang B; Chen J; Lin C; Liu R; Wang L; Yuan C
    Mini Rev Med Chem; 2022; 22(16):2138-2145. PubMed ID: 35156580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA MYOSLID functions as a competing endogenous RNA to regulate MCL-1 expression by sponging miR-29c-3p in gastric cancer.
    Han Y; Wu N; Jiang M; Chu Y; Wang Z; Liu H; Cao J; Liu H; Xu B; Xie X
    Cell Prolif; 2019 Nov; 52(6):e12678. PubMed ID: 31497917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DUXAP8: A Promising lncRNA with Carcinogenic Potential in Cancer.
    Wang B; Xu W; Cai Y; Chen J; Guo C; Zhou G; Yuan C
    Curr Med Chem; 2022; 29(10):1677-1686. PubMed ID: 34313198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNA DLEU2 and ROR1 pathway induces epithelial-to-mesenchymal transition and cancer stem cells in breast cancer.
    Islam SS; Al-Tweigeri T; Al-Harbi L; Ujjahan S; Al-Mozaini M; Tulbah A; Aboussekhra A
    Cell Death Discov; 2024 Jan; 10(1):61. PubMed ID: 38296962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA MYU promotes prostate cancer proliferation by mediating the miR-184/c-Myc axis.
    Wang J; Yang X; Li R; Wang L; Gu Y; Zhao Y; Huang KH; Cheng T; Yuan Y; Gao S
    Oncol Rep; 2018 Nov; 40(5):2814-2825. PubMed ID: 30132573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. lncRNA MEG3 inhibits pituitary tumor development by participating in cell proliferation, apoptosis and EMT processes.
    Wang X; Li X; Wang Z
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long Non-coding RNA DLGAP1-AS1 and DLGAP1-AS2: Two Novel Oncogenes in Multiple Cancers.
    Zhao F; Tan F; Tang L; Du Z; Chen X; Yang Y; Zhou G; Yuan C
    Curr Med Chem; 2023; 30(25):2822-2834. PubMed ID: 36121088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long noncoding RNA
    He X; Yu B; Kuang G; Wu Y; Zhang M; Cao P; Ou C
    J Cancer; 2021; 12(2):428-437. PubMed ID: 33391439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.